Rio Cole, DO
Hospitalist · Kailua, HINPI 1548520109
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,952 of the $2,852 with a category attached, or 68.4%. 4 manufacturers reported payments, led by Johnson & Johnson at 46.7% of the total. Reporting peaked in 2024 at $1,309 and has fallen 78.3% since, to $283 in 2025. Among hospitalist clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $53.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Gilead$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$422
- Covidien LP$91
What the payments were for
- Consulting fees$90032%
- Food & beverage$1,95268%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 30 | $1,331 |
| Gilead | 2 | $1,008 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $422 |
| Covidien LP | 1 | $91 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,852 in reported general payments places this provider in the 95th percentile of 138 hospitalist providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 31 | $550 |
| Pantoprazole Sodium | 42 | $476 |
| Potassium Chloride | 29 | $384 |
| Atorvastatin Calcium | 19 | $247 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $131 |
| Metoprolol Succinate | 20 | $100 |
| Prednisone | 35 | $97 |
| Ciprofloxacin Hcl | 12 | $66 |
| Amlodipine Besylate | 11 | $49 |
| Carvedilol | 11 | $45 |
| Oxycodone Hcl | 20 | $39 |
| Furosemide | 20 | $31 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Kailua
- Gregory HsuHonolulu$3K
- Teodora TopalovskiAiea$3K
- Ashley OnoHonolulu$2K
- Christine WangHonolulu$2K
- Imtiaz BangashHonolulu$1K
- Cedric StrongWailuku$1K
- Grant ChenHonolulu$1K
- Ryan RaoHonolulu$1K
- Genevieve LeyHonolulu$1K
- Hezhi GanHonolulu$973
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.